Thus, we identified a novel CBX3 (7p15.2)::CCDC32 (15q15.1) gene fusion in AML patients, which has a frequency of 25 % (4 +/16 patients) among our screened AML cases. This evidence concerns the gene CBX3 and acute myeloid leukemia.